Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis. Stüve O, Marra CM, Bar-Or A, Niino M, Cravens PD, Cepok S, Frohman EM, Phillips TJ, Arendt G, Jerome KR, et al. Arch Neurol. 2006 Oct; 63(10):1383-7. PMID: 17030653. Abstract CommentRecommendBookmarkWatch